Niranjan Y. Sardesai
ECRI Institute(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, HIV Research and Treatment, Transgenic Plants and Applications, Immune Cell Function and Interaction, Microbial Inactivation Methods
Most-Cited Works
- → Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial(2015)696 cited
- → Electroporation delivery of DNA vaccines: prospects for success(2011)412 cited
- → Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses(2012)280 cited
- → A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates(2015)252 cited
- → Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery(2013)196 cited
- → Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial(2024)189 cited
- → A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates(2011)174 cited
- → Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus(2008)174 cited
- → MESOMARK™: A Potential Test for Malignant Pleural Mesothelioma(2007)141 cited
- → Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens(2008)137 cited